financetom
Business
financetom
/
Business
/
Royal Bank of Canada's Fiscal Q4 Adjusted Earnings, Revenue Increase; Quarterly Dividend Raised
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Royal Bank of Canada's Fiscal Q4 Adjusted Earnings, Revenue Increase; Quarterly Dividend Raised
Dec 4, 2024 3:39 AM

06:23 AM EST, 12/04/2024 (MT Newswires) -- Royal Bank of Canada ( RY ) reported fiscal Q4 adjusted earnings Wednesday of 3.07 Canadian dollars ($2.18) per share, up from CA$2.65 a year earlier.

Analysts polled by FactSet expected CA$3.01.

Total revenue for the quarter ended Oct. 31 was CA$15.07 billion, up from CA$12.69 billion a year earlier.

Analysts surveyed by FactSet expected CA$14.72 billion.

Separately, the company said it raised its quarterly dividend by 4% to CA$1.48 per share, payable around Feb. 24 to shareholders as of Jan. 27.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Universal Health Services Q4 Adjusted Earnings, Revenue Increase -- Shares Rise After Hours
Universal Health Services Q4 Adjusted Earnings, Revenue Increase -- Shares Rise After Hours
Feb 26, 2025
04:48 PM EST, 02/26/2025 (MT Newswires) -- Universal Health Services ( UHS ) reported Q4 adjusted earnings late Wednesday of $4.92 per diluted share, up from $3.13 a year earlier. Analysts polled by FactSet expected $4.14. Net revenue for the quarter ended Dec. 31 was $4.11 billion, up from $3.70 billion a year earlier. Analysts surveyed by FactSet expected $4.01...
Chemed Q4 Adjusted Earnings, Revenue Rise; 2025 Outlook Set
Chemed Q4 Adjusted Earnings, Revenue Rise; 2025 Outlook Set
Feb 26, 2025
04:49 PM EST, 02/26/2025 (MT Newswires) -- Chemed ( CHE ) reported Q4 adjusted earnings late Wednesday of $6.83 per diluted share, up from $6.60 a year earlier. Three analysts surveyed by FactSet expected $6.78. Revenue for the quarter ended Dec. 31 was $640 million, up from $585.9 million a year earlier. Three analysts polled by FactSet expected $636.1 million....
O Reilly Automotive Insider Sold Shares Worth $2,667,481, According to a Recent SEC Filing
O Reilly Automotive Insider Sold Shares Worth $2,667,481, According to a Recent SEC Filing
Feb 26, 2025
04:47 PM EST, 02/26/2025 (MT Newswires) -- Jason Lee Tarrant, Executive Vice President, Store Operations & Sales, on February 25, 2025, sold 1,992 shares in O Reilly Automotive (ORLY) for $2,667,481. Following the Form 4 filing with the SEC, Tarrant has control over a total of 1,459 common shares of the company, with 1,398 shares held directly and 61 controlled...
Sarepta Therapeutics Q4 Non-GAAP Earnings, Revenue Rise
Sarepta Therapeutics Q4 Non-GAAP Earnings, Revenue Rise
Feb 26, 2025
04:48 PM EST, 02/26/2025 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) reported Q4 non-GAAP net earnings late Wednesday of $1.90 per diluted share, up from $0.82 a year earlier. Analysts polled by FactSet expected $2.00. Total revenue for the quarter ended Dec. 31 was $658.4 million, up from $396.8 million a year earlier. Analysts surveyed by FactSet expected $636.1...
Copyright 2023-2026 - www.financetom.com All Rights Reserved